Instil Bio News

Latest Instil Bio Stock News & TIL Headlines

Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)

18 days ago | globenewswire.com

Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy

18 days ago | globenewswire.com

Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026

21 days ago | globenewswire.com

Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma

24 days ago | globenewswire.com

Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026

a month ago | globenewswire.com

Iovance Maps TIL Therapy Expansion After Record Revenue and Margin Gains

2 months ago | marketbeat.com

Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

3 months ago | globenewswire.com

Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million

3 months ago | gurufocus.com

Iovance: The Worst May Be Behind This TIL Pioneer (Upgrading To Buy)

4 months ago | seekingalpha.com

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

5 months ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

TIL

Instil Bio

$ 6.08

-2.56%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Instil Bio News

Latest Instil Bio Stock News & TIL Headlines

Download App

People Also Watch

Explore our Tools